News & Events about Organogenesis Holdings Inc.
Globe Newswire
2 months ago
NEW YORK, Nov. 19, 2022 (GLOBE NEWSWIRE) -- Sleep Number Corporation (NASDAQ: SNBR) Lifshitz Law PLLC announces that a class action complaint was filed on behalf of shareholders of Sleep Number alleging that Defendants made false and misleading statements and failed to disclose that: (i) Sleep ...
Organogenesis Holdings Inc. (NASDAQ:ORGO Get Rating) Equities researchers at Oppenheimer dropped their FY2023 EPS estimates for shares of Organogenesis in a note issued to investors on Thursday, November 10th. Oppenheimer analyst S. Lichtman now expects that the company will post earnings per share ...
Globe Newswire
4 months ago
CANTON, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today ...
Thinking about buying stock in Selecta Biosciences, Adial Pharmaceuticals, Exela Technologies, Theravance Biopharma, or Organogenesis? Thinking about buying stock in Selecta Biosciences, Adial Pharmaceuticals, Exela Technologies, Theravance Biopharma, or Organogenesis? PR Newswire NEW YORK, July...
Organogenesis Holdings Inc. (NASDAQ:ORGO Get Rating) major shareholder Albert Erani sold 100,000 shares of the stock in a transaction that occurred on Monday, June 6th. The shares were sold at an average price of $5.41, for a total value of $541,000.00. Following the transaction, the insider now ...